Hematology !70% 1 / 12 · unit 2 of 5
What the card badges mean

textbook — checked against your assigned chapter. The standard this exam is measured against.

slides — backed by your instructor's own deck, not (yet) the textbook. A different promise, not a lesser one — she writes the exam from these.

webinar or plain unchecked — nobody has verified this against any source yet. That means unconfirmed, not known wrong.

over any of the above — a caution: only part of the concept is backed, or the wording claims more than its source states.

!conflict — two sources disagree; both versions are on the card.

Pathophysiology of microcytic, macrocytic, and normocytic anemias

Topic 12 of 73 !conflict

Anemia gets sorted into three buckets by asking one question first: how big are the red blood cells? That single measurement — MCV — points you toward the cause before you look at anything else.

MCV stands for mean corpuscular volume: the average size of a red blood cell, measured in femtoliters (fL). It's the first fork in the road for figuring out why someone is anemic.

MICROCYTIC (small cells)NORMOCYTIC (normal-sized cells)MACROCYTIC (large cells)
MCVLess than 80 fL80–100 fLGreater than 100 fL
Core problemThe cell can't build enough hemoglobinEither not enough cells are being made, or cells are being destroyed/lost too fastThe cell can't finish copying its DNA properly before it has to divide
CausesIron deficiency, thalassemia, anemia of chronic disease, sideroblastic anemiaAnemia of chronic disease, CKD (low EPO), aplastic anemia, acute blood loss, hemolysisB12 deficiency, folate deficiency, alcohol, liver disease, hypothyroidism

Why microcytic cells end up small:

Building hemoglobin requires enough iron, copper and vitamin B6 on hand — note that is B6, not B12. Careful here: your Key Points handout lists B12 in this slot instead. The textbook says B6, and the handout itself puts B12 under macrocytic two paragraphs later — so B6 is the one that holds up. Worth asking your instructor which she wants. B12 deficiency does the opposite, making cells too big. When iron stores run short, the cell simply can't manufacture as much hemoglobin, so it comes out smaller and paler than normal (this paleness is called hypochromic).

Why macrocytic cells end up large:

A B12 or folate shortage slows down DNA synthesis — the step where the cell's nucleus has to finish copying its genetic material before the cell can divide. The nucleus lags behind while the cytoplasm around it keeps growing, so the cell balloons up before it's ready to split. That oversized, immature cell is called a MEGALOBLAST.

Why normocytic anemia is the trickiest of the three:

Here the cells are a completely normal size, so MCV gives you no clue at all — the problem lies in either how many cells are being made or how long they survive, not in how they're built. To tell those two apart you need the RETICULOCYTE COUNT (a reticulocyte is a young, newly-released red cell) — covered in more detail in unit2c10.

How B12 actually gets from your plate into your blood (the pathway your course wants you to know):

  1. You eat B12 in food.
  2. In the STOMACH, it's released from the protein it was bound to.
  3. It binds to INTRINSIC FACTOR.
  4. That B12–intrinsic-factor pair travels down and gets absorbed in the ILEUM (the last stretch of the small intestine).

A break at any point in that chain — stomach, intrinsic factor, or ileum — causes a B12 deficiency, even if the diet itself is fine.

B12 is required to build MYELIN, the insulating sheath around nerves. That's the reason a B12 deficiency causes neurologic symptoms — and it's the detail that separates B12 deficiency from folate deficiency (see unit2c3).

How the body compensates (this is from your key points):

Fewer red cells means less oxygen being carried, and that's what produces the fatigue and shortness of breath. The body's answer is to raise the heart rate and cardiac output — pushing the red cells it still has around the body faster. That's why a chronically anemic patient is tachycardic, and why anemia that goes on for a long time eventually strains the heart.

Stepping back: what causes anemia in the first place?

  • Blood loss — sudden (trauma) or slow and ongoing (a bleeding ulcer, heavy periods)
  • Not enough cells being made — the marrow can't keep up
  • Cells being destroyed too fast — they're breaking down faster than they're replaced
  • A combination of the above
Careful — your Key Points and the textbook disagree here. Your handout adds a fourth cause, hemodilution (extra fluid in the blood watering it down). The textbook deliberately leaves it out: it defines anemia as a real drop in the number of red cells, not an apparent drop caused by extra plasma. Both are worth knowing. Watering down really does lower the measured hematocrit — the book says exactly that about the first day after a big bleed — the book just doesn't call that anemia. Worth asking your instructor which answer she wants.

One more on normocytic — your key points go wider than the table above:

Normocytic is the bucket where cell size tells you nothing, so the list of possible causes is the question. Anything that hits red cell production, maturation or lifespan: chronic inflammatory disease, kidney disease, endocrine disorders, bone marrow disorders, nutritional deficiencies, and chronic hemoglobinopathies. The last three are the ones the table leaves out.

MICROCYTICNORMOCYTICMACROCYTIC
MCVLess than 80 fL80–100 fLGreater than 100 fL
Core problemImpaired hemoglobin synthesisDecreased production OR increased destruction/lossDeficient DNA synthesis
CausesIron deficiency, thalassemia, anemia of chronic disease, sideroblasticAnemia of chronic disease, CKD (low EPO), aplastic anemia, acute blood loss, hemolysisB12 deficiency, folate deficiency, alcohol, liver disease, hypothyroidism
  • Microcytic mechanism: hemoglobin synthesis requires adequate IRON, COPPER and VITAMIN B6 (pyridoxine) — the textbook's answer. YOUR KEY POINTS SAY B12 HERE INSTEAD, but the same handout puts B12 under MACROCYTIC two paragraphs later, and so does the book. Know both; B6 is the one that survives cross-checking. Iron store deficits reduce hemoglobin synthesis, producing smaller, paler cells (hypochromic).
  • Macrocytic mechanism: B12 or folate shortage impairs DNA synthesis during RBC production. The nucleus develops slowly while cytoplasm accumulates, producing large immature MEGALOBLASTS.
  • Normocytic mechanism: cell size is normal, so the problem is production or survival, not synthesis. The RETICULOCYTE COUNT tells you which.
  • How the body compensates (your key points). Fewer red cells means less oxygen carried, which gives the FATIGUE and SHORTNESS OF BREATH. The body answers by raising HEART RATE and CARDIAC OUTPUT to push the remaining cells around faster. That is why a chronically anemic patient is tachycardic, and why long-standing anemia eventually strains the heart.
  • The fuller normocytic list (your key points go wider than the table). Anything hitting red cell PRODUCTION, MATURATION or LIFESPAN: chronic inflammatory disease, KIDNEY disease, ENDOCRINE disorders, BONE MARROW disorders, NUTRITIONAL deficiencies, and chronic HEMOGLOBINOPATHIES. The last three are the ones the table leaves out.
  • B12 absorption pathway (your course details this): dietary intake → released from protein in the STOMACH → binds INTRINSIC FACTOR → absorbed in the ILEUM. A break anywhere in that chain causes deficiency. B12 is required for MYELIN synthesis, which is why deficiency causes neurologic symptoms.
  • What causes anemia at all — and one disputed cause. The textbook names BLOOD LOSS (acute or chronic), IMPAIRED PRODUCTION, INCREASED DESTRUCTION, or a combination of those. YOUR KEY POINTS ADD HEMODILUTION as a fourth. The book excludes it deliberately: it defines anemia as a TRUE fall in red cell numbers, not a relative fall caused by extra plasma volume. Both are worth holding — dilution really does drop the measured hematocrit (the book says exactly that about the first day after acute blood loss); the book just does not call that anemia.

Sources for this card

  • Textbook McCance Ch. 28-29, incl. Tables 28.6 and 29.1

    Table 29.1 confirms the three mechanisms. A correction fixed vitamin B12, which the guide had listed as a MICROCYTIC nutrient; the book pairs B6 with microcytic and B12 with macrocytic.

  • Key Points Unit 2 Key Points — “Anemia / Microcytic / Macrocytic / Normocytic Anemia”

    Backs the definition of anemia, the MCV-based three-way split, and the mechanism of each type — but states the microcytic nutrients as iron, copper and B-12, which is where it parts company with the textbook. See the conflict on this card.

  • Slides Week 2 deck, slide 14

Careful: this card's wording claims more than its sources give it — including, on some cards, a chapter reference nobody has checked yet. Treat any citation in the text above as unconfirmed unless it appears in this list.

Open one and check this card against it. If it disagrees, that is worth reporting.

Pathophysiology of anemia of chronic disease

Topic 13 of 73 textbook

One-sentence version: chronic inflammation makes the body hide its own iron.

The chain, in order:

  1. A chronic infection, inflammatory disease, or cancer keeps triggering inflammatory cytokines. The book's own diagram names three: IL-6, IL-1β and TNF-α.
  2. IL-6 signals the liver to release a hormone called HEPCIDIN.
  3. Hepcidin locks iron away inside macrophages and also blocks the intestine from absorbing new iron from food.
  4. The iron hasn't left the body — it's just UNAVAILABLE for building new red blood cells. This is called a FUNCTIONAL iron deficiency: the iron is present, but locked up where the marrow can't use it.
  5. On top of the iron problem, TNF-α directly dampens red cell production and blunts the kidney's erythropoietin (EPO) response, and red cells don't survive as long in circulation.
Result: a NORMOCYTIC anemia (sometimes microcytic), with NORMAL-TO-HIGH ferritin — because unlike true iron deficiency, the iron never actually left the body.

One-sentence version: chronic inflammation makes the body hide its own iron.

  1. Chronic infection, inflammatory disease, or malignancy → inflammatory cytokines — the book's figure names IL-6, IL-1β and TNF-α
  2. IL-6 → the liver releases HEPCIDIN
  3. Hepcidin SEQUESTERS IRON IN MACROPHAGES and blocks intestinal absorption
  4. Iron is present in the body but UNAVAILABLE — a FUNCTIONAL iron deficiency
  5. Additionally: impaired erythropoiesis, blunted EPO response, and reduced RBC lifespan
  6. Result: NORMOCYTIC (sometimes microcytic) anemia with NORMAL-TO-HIGH ferritin

Sources for this card

  • Textbook McCance Ch. 29 — Anemia of Inflammation, incl. Fig. 29.6 and Table 29.1

    Confirms the whole chain: IL-6 and IL-1-beta drive the liver to make hepcidin; hepcidin cuts iron export and gut absorption; TNF-alpha suppresses the marrow and blunts the kidney's EPO. Labs confirmed too, and the book says AI starts normocytic and turns microcytic only with persistence — as the card says.

  • Key Points Unit 2 Key Points — anemia of chronic disease

    Agrees; no disagreement found.

  • Slides Week 2 deck, slide 24

Open one and check this card against it. If it disagrees, that is worth reporting.

Pathophysiology of folate deficiency

Topic 14 of 73 !conflict

Folate (vitamin B9) is needed for DNA synthesis, just like B12. Without enough of it, red cell production produces the same kind of oversized, immature cell described in unit2c1 — a MEGALOBLASTIC macrocytic anemia.

Large, immature megaloblasts pile up in the bone marrow, and fewer fully mature red blood cells make it out into circulation.

Lab pattern to recognize:

  • Folate — LOW
  • RBCs — normal or low
  • MCV — HIGH
  • MCHC — normal
  • Reticulocyte count — normal or elevated (this is slide 22's wording. Your textbook disagrees: it files every megaloblastic anemia under "not enough being made," where reticulocytes are LOW, and says so outright for pernicious anemia. Know both — if the question is about the marrow failing to respond, the answer is low.)
  • Serum iron — normal or decreased

Who's most at risk:

  • Alcoholics — the classic association; alcohol use makes folate deficiency easy to develop
  • Pregnancy
  • Malabsorption
  • Poor diet
  • Methotrexate

The cleanest way to tell folate and B12 apart — where they're absorbed:

Folate is absorbed high up, in the upper small intestine, and needs no intrinsic factor to get in. B12 needs intrinsic factor and is absorbed much further down, in the ileum. That single difference explains a lot: stomach disease and ileal surgery starve you of B12, but not of folate.

Folate deficiency's own signs (these are its, not B12's):

  • Cheilosis — cracks and scaling at the corners of the mouth
  • Stomatitis — an inflamed, sore mouth
  • Painful ulcers on the inner cheek and tongue — sometimes called burning mouth
  • Dysphagia (trouble swallowing), flatulence, watery diarrhea
THE DISCRIMINATOR — do not mix this up: B12 deficiency causes NEUROLOGIC symptoms (peripheral neuropathy, numbness and tingling in the lower legs/feet, balance problems), because B12 is needed to build myelin. Folate deficiency does NOT cause neurologic symptoms — everything else about the two anemias can look identical on a basic blood count, but this is the tell. One caveat from the book, so a real patient doesn't throw you: a folate-deficient person can have neurologic signs — but they come from the thiamine deficiency that travels alongside malnutrition, not from the folate itself. The rule still holds.
  • Folate (vitamin B9) is required for DNA synthesis; deficiency produces a MEGALOBLASTIC macrocytic anemia
  • Large, immature megaloblasts appear in the marrow; fewer mature RBCs reach circulation
  • Lab parameters: folate LOW · RBCs normal or low · MCV HIGH · MCHC normal · reticulocyte count normal or elevated (THAT IS SLIDE 22'S WORDING — the textbook files megaloblastic anemia under UNDERPRODUCTION, where reticulocytes are LOW, and says so outright for pernicious anemia. Know both; if the question is about the marrow failing to respond, the answer is low.) · serum iron normal or decreased
  • At-risk populations: ALCOHOLICS (classic — alcoholics can easily become folate deficient), pregnancy, malabsorption, poor diet, methotrexate
  • The structural discriminator (cleaner than the symptom one): FOLATE is absorbed in the UPPER SMALL INTESTINE and needs NO intrinsic factor. B12 needs INTRINSIC FACTOR and is absorbed in the ILEUM. That is why stomach disease and ileal resection cause B12 deficiency but not folate deficiency.
  • Folate's own signs: CHEILOSIS (scales and fissures at the corners of the mouth), STOMATITIS, and painful ulcers of the inner cheek and tongue — burning mouth. Also dysphagia, flatulence and watery diarrhea.
THE DISCRIMINATOR: B12 deficiency causes NEUROLOGIC symptoms (peripheral neuropathy, numbness and tingling in the lower extremities, balance problems). Folate deficiency does NOT. One caveat from the book so this does not trip you up: a folate-deficient patient CAN have neurologic signs, but they come from the THIAMINE deficiency that travels with malnutrition, not from the folate. The discriminator still holds.

Sources for this card

  • Textbook McCance Ch. 29 — folate deficiency

    Confirms folate as a megaloblastic macrocytic anemia and the risk groups. Two additions: folate is absorbed in the UPPER SMALL INTESTINE with no intrinsic factor (the contrast with B12), and its own signs — cheilosis, stomatitis, mouth ulcers. Disagrees with slide 22 on the reticulocyte count.

  • Key Points Unit 2 Key Points — folate deficiency
  • Slides Week 2 deck, slide 22

    The card's lab panel is a verbatim transcription of this slide.

Only part of this card is covered by the sources listed. The rest is not yet backed by anything we hold.

Open one and check this card against it. If it disagrees, that is worth reporting.

Pathophysiology of sickle cell anemia

Topic 15 of 73 textbook

Sickle cell anemia is an autosomal recessive condition — you need a copy of the faulty gene from both parents to have the disease. A single point mutation swaps out one amino acid, valine in place of glutamic acid, at position 6 of the beta-globin chain that makes up hemoglobin. The abnormal hemoglobin this produces is called HbS. The word for this is a HEMOGLOBINOPATHY — the book's term for a hemoglobin whose globin chain is built wrong. It sets that against hemoglobin that isn't built in sufficient quantity, which is the thalassemias. Same family, two different faults: sickle cell is the misshapen one, thalassemia is the not-enough-made one. Your key points use the word more widely than the book does — for them a hemoglobinopathy is any genetic defect in the **structure or synthesis** of hemoglobin, which makes thalassemia one too. If a question asks you to define the word, give that wider version. The book's narrower split is for telling the two diseases apart.

The problem shows up when HbS gives up its oxygen (deoxygenation): HbS molecules stick together and polymerize inside the cell, physically distorting it into the sickle shape. The resulting cell is rigid and sticky, with reduced flexibility and a shortened lifespan — it can't squeeze through small vessels the way a normal, flexible red cell can, and it dies off faster.

Four mechanisms your course names for why this produces severe anemia:

  1. Rapid turnover — sickled cells break down quickly once they're in the bloodstream.
  2. Splenic sequestration — the spleen traps the malformed cells and destroys them.
  3. Ineffective erythropoiesis — the bone marrow can't keep up with replacing all the cells being destroyed.
  4. Vaso-occlusive crises — rigid sickled cells physically jam up small vessels, cutting off blood flow and causing tissue ischemia (oxygen starvation) and pain.

What triggers a crisis:

  • Hypoxia (low oxygen — the book writes it as low PO2)
  • Dehydration
  • Infection
  • Acidosis
  • Cold
  • Constricting clothing — the only one on the book's list she can control herself
  • Physical or emotional stress
  • High altitude
  • …or nothing at all. The book is clear that a crisis can also start spontaneously, with no trigger.

Complications to know:

  • Vaso-occlusive pain crisis
  • Acute chest syndrome
  • Autosplenectomy (the spleen destroys itself over repeated sickling) → this leaves the patient at high risk for infection from encapsulated organisms, which is why pneumococcal vaccination matters
  • Stroke
  • Priapism
  • Avascular necrosis

The four named crises — the book sorts the sudden attacks into four:

CrisisWho / what sets it offHow you recognise it
Vaso-occlusive (pain crisis)The one she already knows — sickled cells jam small vessels.Severe pain from tissue starved of blood.
AplasticA viral infection, classically parvovirus B19.The marrow simply stops making red cells for a while. Hemoglobin drops fast and the reticulocyte count is extremely low — that low count is the giveaway. Lasts about 7 to 10 days.
SequestrationChildren under 5.Red cells pool suddenly in the liver and spleen. The spleen can hold up to a fifth of the whole blood supply, so she can go hypovolemic and even into shock.
HyperhemolyticRare — certain drugs or infections. G6PD deficiency makes it more likely, especially with an infection, and it can also follow a blood transfusion.Red cells are being destroyed faster than the bone marrow can replace them — so even though the marrow is working hard (high reticulocyte count), the hemoglobin still drops. You get anemia and jaundice. Dark urine can show up too: the hemoglobin spilled from all those broken cells gets cleared through the kidney. (Dark urine is your addition — the book describes it for other hemolytic anemias, not for this crisis specifically.)
Sickle cell trait is not sickle cell disease. If a child gets HbS from one parent and normal HbA from the other, that is the carrier state. The book says it rarely causes any symptoms and is not counted as a form of sickle cell disease at all. This is a favourite trick answer.

Treatment:

  • Hydration
  • Oxygen — but only if she is actually hypoxic. The book says it is not needed otherwise.
  • Pain control
  • Hydroxyurea — raises fetal hemoglobin (HbF)
  • Folic acid
  • Transfusion
  • Penicillin prophylaxis in children
  • Vaccination
  • Autosomal recessive HEMOGLOBINOPATHY — the book's word for a STRUCTURALLY abnormal globin chain, which it sets against DEFICIENT globin synthesis (the thalassemias). Both are inherited hemoglobin defects; sickle cell is the structural one, thalassemia is the not-enough-made one. YOUR KEY POINTS USE THE WORD MORE WIDELY — any genetic defect in the STRUCTURE OR SYNTHESIS of hemoglobin, which makes thalassemia a hemoglobinopathy too. If you are asked to DEFINE the word, give that wider one; the book's split is for telling the two diseases apart. A point mutation substitutes VALINE for GLUTAMIC ACID at position 6 of the beta-globin chain, producing HbS
  • On DEOXYGENATION, HbS polymerizes and the RBC sickles — becoming rigid and sticky with REDUCED FLEXIBILITY AND SHORTENED LIFESPAN

Four mechanisms your course names for the severe anemia:

  1. RAPID TURNOVER of sickled cells in the bloodstream
  2. SPLENIC SEQUESTRATION — malformed cells are trapped and destroyed in the spleen
  3. INEFFECTIVE ERYTHROPOIESIS — the marrow cannot adequately replace destroyed cells
  4. VASO-OCCLUSIVE CRISES — causing tissue ischemia and pain
  • Triggers: hypoxia (low PO2), dehydration, infection, acidosis, cold, CONSTRICTING CLOTHING, physical or emotional stress, high altitude. The book adds that a crisis can also arise spontaneously, with no trigger at all.
  • Complications: vaso-occlusive pain crisis, acute chest syndrome, autosplenectomy → high risk for ENCAPSULATED ORGANISMS (hence pneumococcal vaccination), stroke, priapism, avascular necrosis
  • THE FOUR NAMED CRISES — the book classes the acute attacks into four, and they are told apart by trigger, age and labs: (1) VASO-OCCLUSIVE (pain) — sickled cells jam the microcirculation, causing ischemia and severe pain. (2) APLASTIC — RBC production stops transiently after a viral infection (parvovirus B19); hemoglobin drops suddenly with an EXTREMELY LOW RETICULOCYTE COUNT, and it lasts 7 to 10 days. (3) SEQUESTRATION — children UNDER 5; RBCs pool acutely in the liver and spleen, and because the spleen can hold up to a FIFTH of the blood supply, hypovolemia and even shock follow. (4) HYPERHEMOLYTIC — rare; accelerated destruction of red blood cells, with certain drugs or infections, giving anemia, jaundice and RETICULOCYTOSIS. The reticulocytosis is the tell: unlike the aplastic crisis, the marrow is responding hard — the cells are just being destroyed faster than the marrow can replace them, so the hemoglobin still falls. Two more from the chapter: G6PD deficiency contributes, especially alongside an infection, and it can also follow a blood transfusion. (Your addition — dark urine: free hemoglobin from the destroyed cells is cleared through the kidney. The book describes that for other hemolytic anemias; the sickle-cell chapter does not list it for this crisis specifically, so it is a real finding rather than the chapter's own wording.)
  • SICKLE CELL TRAIT (HbAS) IS NOT SICKLE CELL DISEASE. The child inherits HbS from one parent and normal HbA from the other. The book states this heterozygous carrier state rarely has clinical manifestations and IS NOT REGARDED AS A FORM OF SCD — a standard distractor.
  • Treatment: hydration, OXYGEN ONLY IF HYPOXIC (the text says it is not needed otherwise), pain control, HYDROXYUREA (raises HbF), folic acid, transfusion, penicillin prophylaxis in children, vaccination

Sources for this card

  • Textbook McCance Ch. 30 — sickle cell disease; Ch. 29 Table 29.3

    Every claim on the card is in Ch. 30, spot-checked item by item: priapism, avascular necrosis, acute chest syndrome, autosplenectomy, encapsulated organisms, penicillin, hydroxyurea, ineffective erythropoiesis, sequestration, and the trigger list nearly verbatim. Ch. 29 Table 29.3 gave the hemoglobinopathy definition.

  • Key Points Unit 2 Key Points — sickle cell anemia

Open one and check this card against it. If it disagrees, that is worth reporting.

Red blood cell production and the role of erythropoietin

Topic 16 of 73 textbook

Red blood cells carry oxygen from the lungs out to the tissues, and carry carbon dioxide back to the lungs. They're produced through a process called erythropoiesis, which happens in the bone marrow.

The signal that tells the marrow to make more red cells is erythropoietin (EPO), and it's produced mainly by the kidney — specifically in response to tissue hypoxia (the kidney sensing that tissues aren't getting enough oxygen). EPO then travels through the blood to the marrow and stimulates the progenitor cells that will become red blood cells to ramp up production.

Two clinical consequences worth memorizing — the direction of each one matters:

  1. CKD (chronic kidney disease): damaged kidneys make less EPO → less signal to the marrow → normocytic anemia. This is why kidney disease patients are commonly anemic — it's an EPO problem, not an iron problem.
  2. COPD: chronically low oxygen levels → the kidney senses hypoxia and makes more EPO → secondary polycythemia (too many red cells) → thicker, more viscous blood, which contributes to pulmonary hypertension.
  • RBCs transport oxygen from the lungs to tissues and return carbon dioxide to the lungs
  • RBCs are produced by ERYTHROPOIESIS in the bone marrow
  • ERYTHROPOIETIN IS PRODUCED PRIMARILY BY THE KIDNEY in response to TISSUE HYPOXIA
  • EPO travels to the marrow and stimulates erythroid progenitors to increase RBC production
Two clinical consequences worth memorizing: (1) CKD → decreased EPO → NORMOCYTIC ANEMIA. This is why kidney patients are anemic. (2) COPD → chronic hypoxia → increased EPO → SECONDARY POLYCYTHEMIA → increased blood viscosity, contributing to pulmonary hypertension.

Sources for this card

  • Textbook McCance Ch. 28 — erythropoiesis and the EPO feedback loop; Ch. 29 — polycythemia

    Every claim confirmed. In tissue hypoxia, EPO is secreted primarily by the PERITUBULAR CELLS OF THE KIDNEY and binds receptors on marrow proerythroblasts. Both consequences hold: EPO deficiency in renal failure causes anemia, and COPD is named among the chronic-hypoxia causes of secondary polycythemia.

  • Key Points Unit 2 Key Points — red blood cell production
  • Slides Week 2 deck, slide 24

Open one and check this card against it. If it disagrees, that is worth reporting.

Lab markers used in diagnosing anemia

Topic 17 of 73 textbookYour school words it: “Lab markers used in diagnosing anemia (e.g. iron deficiency and vitamin B-12 deficiency)”

Three lab markers used to work up anemia:

  • MCV (mean corpuscular volume) — the average red cell size, in femtoliters. This is what sorts anemia into microcytic, normocytic, or macrocytic (unit2c1).
  • Ferritin — reflects how much iron is stored in the whole body. A low ferritin points toward iron deficiency, but on its own it does NOT tell you which anemia you're dealing with — you need the rest of the iron studies below to be sure.
  • RDW (red cell distribution width) — measures how much the red cells vary in size from one another. It's one of the earliest markers to shift as a microcytic or macrocytic anemia is developing.
  • The normal adult ranges (from the book's own table), so there is something to compare against: hemoglobin 13.5–18.0 g/dL in men and 12.5–16.0 in women; hematocrit 42–52% in men and 37–47% in women; reticulocytes 0.5–1.5%; MCV 78–100 fL; white cells 4.0–10.5 thousand. Only hemoglobin and hematocrit differ by sex — the rest are the same for everyone.

What each test actually measures — read this first:

  • Serum ferritin. Ferritin is where your body stores iron. Your textbook traces the whole path: iron sticks to transferrin in the blood, gets carried to macrophages, and is stored there as ferritin. So this test reads your iron savings account — low ferritin means the savings are spent, which points at iron deficiency. ✓ in your book
  • Serum iron. How much iron is floating in the blood right now — the cash in your pocket, not the savings. (Standard definition; your chapter uses the number but never defines the test.)
  • Transferrin. The delivery truck — the protein that carries iron around the bloodstream. Same sentence in your book as the ferritin one above. ✓ in your book
  • Transferrin saturation. What fraction of those trucks are actually loaded. Your book's wording: the percentage of transferrin that is saturated with iron. ✓ in your book
  • TIBC (total iron-binding capacity). How much iron the blood could carry if every truck were full — the size of the fleet. Your book defines it as the iron in serum plus the transferrin available in serum. ✓ in your book
  • Hemoglobin (Hgb). The oxygen-carrying protein inside a red blood cell — your book's own phrase. ✓ in your book
  • Hematocrit (Hct). What percentage of your blood volume is made up of red cells. (Standard definition; your chapter uses it constantly but never stops to define it.)

Once you have those, the grid below stops being something to memorise cold. Take iron deficiency: the savings are empty (ferritin down), so there is little iron in circulation (serum iron down), the body builds more trucks to scavenge whatever it can find (TIBC up), and most of those trucks drive around empty (transferrin saturation down).

Iron studies — the table to memorize:

TestIRON DEFICIENCYTHALASSEMIAANEMIA OF CHRONIC DISEASESIDEROBLASTIC
Serum ferritin (stored iron)DECREASEDIncreasedNormal to increasedNormal to increased
RDW (size variation)INCREASEDNormal to increasedNormalIncreased
Serum iron (circulating iron)DECREASEDNormal to increasedNormal to decreasedNormal to increased
Total iron-binding capacity (TIBC — how much more iron the blood COULD carry)INCREASEDNormalSlightly decreasedNormal
Transferrin saturation (% of that carrying capacity actually in use)DECREASEDNormal to increasedNormal to slightly decreasedNormal to increased
The pattern that wins points: iron deficiency is the ONLY one of these with LOW ferritin AND HIGH TIBC. Think of TIBC as empty seats on a bus — when there's no iron on board, there are lots of empty seats (high TIBC) because the transport protein is starving for iron to carry.
The adult normal ranges (Table 30.1). Hemoglobin 13.5-18.0 g/dL in men, 12.5-16.0 in women. Hematocrit 42-52% men, 37-47% women. Reticulocytes 0.5-1.5%. MCV 78-100 fL. WBC 4.0-10.5 thousand/mm³. Note only haemoglobin and haematocrit differ by sex — the rest are the same for everyone.
  • MCV (mean corpuscular volume) — average RBC size in femtoliters; classifies anemia as microcytic, normocytic, or macrocytic
  • Ferritin — reflects TOTAL BODY IRON STORES. Low ferritin indicates iron deficiency, but by itself it does NOT tell you the type of anemia until other iron studies are drawn.
  • RDW (red cell distribution width) — measures variation in cell size; one of the EARLIEST markers of a developing microcytic or macrocytic anemia
  • ADULT REFERENCE RANGES (Table 30.1) — HEMOGLOBIN 13.5-18.0 g/dL (male), 12.5-16.0 (female). HEMATOCRIT 42-52% (male), 37-47% (female). RETICULOCYTES 0.5-1.5%. MCV 78-100 fL. WBC 4.0-10.5 thousand/mm3. Note hemoglobin and hematocrit differ by sex; the rest do not.

What each test actually measures — read this before the grid:

  • Serum ferritin — ferritin is the STORAGE form of iron. Ch. 28: iron binds transferrin in the blood, is carried to macrophages, and is stored in the cytoplasm as ferritin. The test estimates body iron stores, so a LOW ferritin means depleted stores → iron deficiency. ✓ textbook
  • Serum iron — how much iron is circulating in the blood right now. (Standard definition; the chapter uses the value but never defines the test.)
  • Transferrin — the TRANSPORT protein that carries iron through the bloodstream — same Ch. 28 sentence as ferritin above. ✓ textbook
  • Transferrin saturation — your book's words: the percentage of transferrin that is saturated with iron. ✓ textbook
  • TIBC (total iron-binding capacity) — your book defines it as the amount of iron in serum PLUS the amount of transferrin available in serum. The intuitive version — how much iron the blood could carry if every site were filled — gets you to the same place. ✓ textbook
  • Hemoglobin (Hgb) — the oxygen-carrying protein of the erythrocyte, in your book's own words. ✓ textbook
  • Hematocrit (Hct) — the percentage of blood volume made up of red cells. (Standard definition; the chapter uses the value throughout but never stops to define it.)

Now the grid makes sense rather than needing to be memorised cold: in IRON DEFICIENCY the stores are empty (ferritin down), so there is little iron circulating (serum iron down), the body makes more carriers to scavenge what it can (TIBC up), and those carriers sit mostly empty (transferrin saturation down).

Iron studies — the table to memorize:

TestIRON DEFICIENCYTHALASSEMIAANEMIA OF CHRONIC DISEASESIDEROBLASTIC
Serum ferritinDECREASEDIncreasedNormal to increasedNormal to increased
RDWINCREASEDNormal to increasedNormalIncreased
Serum ironDECREASEDNormal to increasedNormal to decreasedNormal to increased
Total iron-binding capacityINCREASEDNormalSlightly decreasedNormal
Transferrin saturationDECREASEDNormal to increasedNormal to slightly decreasedNormal to increased

The pattern that wins points: iron deficiency is the ONLY one with LOW ferritin and HIGH TIBC. Think of TIBC as empty seats on a bus — no iron means lots of empty seats.

Sources for this card

  • Textbook McCance Ch. 28 and Ch. 29 — iron studies and the anemia sections

    Two of four columns corroborated. IRON DEFICIENCY: serum iron, ferritin and transferrin saturation all decreased, cells microcytic and hypochromic. CHRONIC DISEASE: low or normal TIBC, normal or high ferritin, low iron. But neither chapter says which way TIBC MOVES in iron deficiency, and neither mentions RDW at all.

  • Slides Week 2 deck, slide 35 (“Lab Values for the Types of Anemia”)

    The card's 20-cell grid is a cell-for-cell transcription of this slide — all four columns, all five rows. The RDW claim is slide 30's wording.

Only part of this card is covered by the sources listed. The rest is not yet backed by anything we hold.

Open one and check this card against it. If it disagrees, that is worth reporting.

Risk factors for iron deficiency anemia

Topic 18 of 73 textbook

Chronic blood loss:

  • Heavy menstrual bleeding
  • GI bleeding
  • NSAID use
  • Frequent blood donation
  • Endometriosis

Increased iron needs:

  • Pregnancy
  • Infancy
  • Growth spurts

Dietary shortage:

  • Poor intake
  • Vegetarian or vegan diet

Decreased absorption:

  • Celiac disease
  • Gastric bypass
  • H. pylori infection

Two more the book names that are easy to forget:

  • Chronic diarrhea — a cause in its own right, and it's neither bleeding nor a diet problem, which is why it slips past people
  • Lead — chronic lead poisoning causes a mild microcytic anemia and blocks iron from being loaded into heme. Watch the loop: iron deficiency causes pica, pica leads to eating lead paint and soil, and together they make an anemia worse than either alone.

Signs and symptoms:

  • Fatigue, weakness, dizziness, dyspnea (shortness of breath)
  • Pallor — check the earlobes, palms and the inside of the lower eyelid
  • Koilonychia — spoon-shaped nails: brittle, thin and ridged, curving upward at the edges
  • Pica (craving non-food items like ice, dirt or starch)
  • Cold intolerance
  • Later on: cheilosis (cracked mouth corners), stomatitis (sore mouth), glossitis (smooth, sore tongue) and trouble swallowing
  • The book notes people often don't seek help until hemoglobin is down to about 7 to 8 g/dL
  • Chronic blood loss — HEAVY MENSTRUAL BLEEDING, GI bleeding, NSAID use, frequent blood donation, endometriosis
  • Increased iron needs — pregnancy, infancy, growth spurts
  • Dietary shortage — poor intake, vegetarian or vegan diet
  • Decreased absorption — celiac disease, gastric bypass, H. pylori infection
  • CHRONIC DIARRHEA — a named cause in the book and easy to forget, since it is neither bleeding nor a diet problem
  • LEAD — chronic lead poisoning gives a mild microcytic anemia and blocks iron from being added to heme. The loop matters: iron deficiency causes PICA, pica leads to eating lead paint and soil, and the two together make an anemia worse than either alone.
  • Signs and symptoms: fatigue, weakness, pallor (earlobes, palms, conjunctivae), KOILONYCHIA — spoon-shaped nails, brittle, thin and ridged — pica, cold intolerance, dyspnea, dizziness. Later: CHEILOSIS, STOMATITIS, GLOSSITIS and dysphagia. The book notes people often do not present until hemoglobin is down to about 7 to 8 g/dL.

Sources for this card

  • Textbook McCance Ch. 29 — iron deficiency anemia

    Names five causes — dietary, impaired absorption, increased requirement, chronic blood loss, CHRONIC DIARRHEA — and confirms most of the card. Chronic diarrhea and LEAD were added from it, with the pica-lead loop. It also names koilonychia and glossitis. Still unsourced: NSAIDs, blood donation, endometriosis.

  • Key Points Unit 2 Key Points — iron deficiency anemia
  • Slides Week 2 deck, slide 29

Only part of this card is covered by the sources listed. The rest is not yet backed by anything we hold.

Open one and check this card against it. If it disagrees, that is worth reporting.

Risk factors for megaloblastic anemia

Topic 19 of 73 textbook

Megaloblastic anemia (the large, immature-cell pattern from B12 or folate deficiency described in unit2c1 and unit2c3) shows up more often in certain groups:

  • Dietary deficiency — vegetarians, vegans, poor nutritional intake
  • Elderly / older adults
  • Malabsorption syndromes — celiac disease, Crohn disease, gastric bypass surgery
  • Pregnancy — increased nutritional needs
  • Chronic alcohol abuse
  • H. pylori infection (interferes with B12 absorption); pernicious anemia (loss of intrinsic factor, the protein B12 needs to be absorbed — see unit2c1)
  • MEDICATIONS — the book gives these a section of their own, and the card had none. Drugs that block DNA synthesis: methotrexate and fluorouracil (chemo), trimethoprim (the sulfa antibiotic), allopurinol, azathioprine and leflunomide. Two of those are everyday prescriptions, which is exactly what makes them good exam material.

Why intrinsic factor goes missing in the first place:

  • Most often an autoimmune attack — the immune system destroys the stomach's parietal cells, or attacks intrinsic factor directly
  • Surgical removal of the stomach, or resection of the ileum (where B12 is absorbed)
  • Tapeworm
  • Alcohol and smoking contribute
  • Dietary deficiency — vegetarians, vegans, poor nutritional intake
  • ELDERLY / older adults
  • Malabsorption syndromes — celiac disease, Crohn disease, gastric bypass surgery
  • PREGNANCY — increased nutritional needs
  • CHRONIC ALCOHOL ABUSE
  • H. pylori infection (affects B12 absorption); pernicious anemia (loss of intrinsic factor)
  • MEDICATIONS — the book gives these their own section, and the card had none. Drugs that block DNA synthesis: METHOTREXATE and fluorouracil (chemo), TRIMETHOPRIM (the sulfa antibiotic), ALLOPURINOL, azathioprine and leflunomide. Two of these are everyday prescriptions, which is what makes them good question material.
  • Why intrinsic factor goes missing: most often an AUTOIMMUNE attack on the gastric parietal cells or on intrinsic factor itself. Also gastrectomy, ILEAL RESECTION and tapeworm. Alcohol and smoking contribute.

Sources for this card

  • Textbook McCance Ch. 29 — megaloblastic anemias, pernicious anemia, drug-induced

    Confirms the dietary, malabsorption, pregnancy and alcohol groups, and adds two the card lacked: MEDICATIONS have their own subsection (methotrexate, trimethoprim, allopurinol, fluorouracil), and the cause of intrinsic factor loss — autoimmune attack on parietal cells, gastrectomy, ileal resection, tapeworm.

  • Key Points Unit 2 Key Points — megaloblastic anemia
  • Slides Week 2 deck, slide 21

Only part of this card is covered by the sources listed. The rest is not yet backed by anything we hold.

Open one and check this card against it. If it disagrees, that is worth reporting.

Risk factors for hemolytic anemia

Topic 20 of 73 textbook

Hemolytic anemia means red cells are being destroyed faster than the marrow can replace them. The causes split into two groups depending on whether the problem is inside the cell or coming from outside it.

Intrinsic (inherited — something wrong with the cell itself):

  • Sickle cell disease
  • G6PD deficiency
  • Hereditary spherocytosis
  • Thalassemia

Extrinsic (acquired — something outside the cell is destroying it):

  • Autoimmune destruction (a Type II hypersensitivity reaction — the immune system attacks its own red cells)
  • Drugs
  • Infections such as malaria
  • Mechanical/prosthetic heart valves (physically shearing cells apart)
  • Transfusion reaction
  • DIC/TTP/HUS
  • Burns

The other question the book asks: where are the cells being destroyed?

  • EXTRAVASCULAR — outside the vessels. Macrophages in the spleen, liver and marrow eat red cells that are antibody-coated, misshapen, or too stiff to squeeze through. The hemoglobin is broken down inside the macrophage, which is why bilirubin rises.
  • INTRAVASCULAR — inside the vessels. The cell bursts where it floats, usually because antibodies fixed complement onto it, or from mechanical injury, parasites or toxins. Hemoglobin spills straight into the plasma.

Supporting labs that confirm hemolysis:

  • Increased reticulocytes — the marrow working overtime to replace what's being lost. In your textbook.
  • Increased indirect (unconjugated) bilirubin — a breakdown product of destroyed hemoglobin. In your textbook.
  • Increased LDH — an enzyme that spills out when cells rupture. On week 1 slide 16.
  • Decreased haptoglobin — haptoglobin's job is to mop up free hemoglobin, so when lots of cells burst it gets used up and the level drops. On week 1 slide 16.
  • A positive Coombs test if the cause is autoimmune. Your book calls this the direct antiglobulin test (DAT) — same test, and DAT is the name to expect in a question.
  • Intrinsic (inherited): sickle cell disease, G6PD deficiency, hereditary spherocytosis, thalassemia
  • Extrinsic (acquired): autoimmune (Type II hypersensitivity), drugs, infections such as malaria, MECHANICAL/PROSTHETIC HEART VALVES, transfusion reaction, DIC/TTP/HUS, burns
  • The other axis — WHERE the cells die. EXTRAVASCULAR: macrophages in the SPLEEN, liver and marrow eat cells that are antibody-coated, misshapen or too stiff. INTRAVASCULAR: cells burst inside the vessel, usually from antibody-driven complement fixation, and also from mechanical injury, intracellular parasites or toxins. This is the axis that explains the labs below.
  • Supporting labs — CONFIRMED in your textbook: increased RETICULOCYTES, and increased INDIRECT (unconjugated) BILIRUBIN. Also on WEEK 1 SLIDE 16, with the reason for each: increased LDH, released when the cells rupture; and DECREASED HAPTOGLOBIN, because haptoglobin is used up binding the free hemoglobin the burst cells spill. (Your textbook chapters do not carry these two — your deck does.) Coombs is what your book calls the DIRECT ANTIGLOBULIN TEST (DAT) — same test, and it is the name to expect in a question.

Sources for this card

  • Textbook McCance Ch. 28 and Ch. 29 — anemias of increased destruction, incl. Table 29.3

    Table 29.3 confirms the inherited/acquired list and names defective cardiac valves outright. The missing axis — extravascular (splenic macrophages) versus intravascular (complement) — was added, since it explains the labs. Unconjugated bilirubin and raised reticulocytes confirmed; Coombs is the book's DAT.

  • Key Points Unit 2 Key Points — hemolytic anemia
  • Slides Week 1 deck, slide 16 — the hemolysis workup

    Carries the whole lab panel with a reason for each: LDH elevated from RBC destruction, haptoglobin decreased because it is consumed binding free hemoglobin, indirect bilirubin elevated, reticulocytes possibly raised. A previous pass searched only Ch. 28/29 and wrongly told the reader these were backed by nothing.

  • Slides Week 2 deck, slide 24

Only part of this card is covered by the sources listed. The rest is not yet backed by anything we hold.

Open one and check this card against it. If it disagrees, that is worth reporting.

Lab markers for normocytic anemia

Topic 21 of 73 textbook

In normocytic anemia, MCV sits right in the normal 80–100 fL range — so cell size gives you no information about what's going on. You have to look elsewhere.

The reticulocyte count is the key discriminator here. A reticulocyte is a young, newly-released red cell, so this count tells you whether the marrow is actively trying to replace lost cells.
  • LOW reticulocytes = a production problem — the marrow isn't making enough cells in the first place (anemia of chronic disease, CKD, aplastic anemia)
  • HIGH reticulocytes = destruction or loss — cells are being lost faster than normal, and the marrow is compensating by pumping out more young cells (hemolysis, acute bleeding)

Supporting labs depending on the suspected cause:

  • Creatinine — points toward CKD
  • Inflammatory markers — point toward anemia of chronic disease
  • LDH / haptoglobin / bilirubin — point toward hemolysis
  • MCV is NORMAL at 80–100 fL — so cell size gives you no information
  • The RETICULOCYTE COUNT is the key discriminator:
  • LOW reticulocytes = a PRODUCTION problem (anemia of chronic disease, CKD, aplastic anemia)
  • HIGH reticulocytes = DESTRUCTION or LOSS (hemolysis, acute bleeding) — the marrow is compensating
  • Supporting labs depending on cause: creatinine (CKD), inflammatory markers (ACD), LDH/haptoglobin/bilirubin (hemolysis)

Sources for this card

  • Textbook McCance Ch. 29 — classification of anemia, incl. Fig. 29.3

    The discriminator is confirmed in prose: decreased production means reticulocytes DECREASED, increased destruction means INCREASED. Fig. 29.3 also settles the MCV boundary in the card's favour — normocytes 80-100 fL, not the Key Points' 80-99. LDH and haptoglobin are not in these chapters; week 1 slide 16 carries them.

  • Key Points Unit 2 Key Points — normocytic anemia
  • Slides Week 2 deck, slide 31

Only part of this card is covered by the sources listed. The rest is not yet backed by anything we hold.

Open one and check this card against it. If it disagrees, that is worth reporting.

Treatment of beta-thalassemia major

Topic 22 of 73 textbook

Treatment, roughly in order of how central it is to management:

  1. Chronic regular blood transfusions — this is the mainstay of therapy.
  2. Iron chelation therapy — because repeated transfusions cause iron overload, patients also need a drug to pull the excess iron back out. Options: deferoxamine (given as a subcutaneous pump infusion), deferasirox (oral, once daily), and deferiprone (oral, and especially good at removing iron specifically from the heart).
  3. Folic acid supplementation.
  4. Splenectomy, in selected cases.
  5. Hematopoietic stem cell transplant — the only actual cure.
The exam point: transfusion is the treatment, but iron overload is the consequence — so chelation always has to go along with it. Do NOT give iron supplements to these patients; they already have too much iron, just delivered by transfusion instead of diet. The most common cause of death in thalassemia major is heart failure from cardiac iron toxicity.
  1. CHRONIC REGULAR BLOOD TRANSFUSIONS — the mainstay of therapy
  2. IRON CHELATION THERAPY — deferoxamine (subcutaneous pump infusion), deferasirox (oral, once daily), deferiprone (oral, especially effective at removing CARDIAC iron). Essential, because repeated transfusions cause IRON OVERLOAD.
  3. Folic acid supplementation
  4. Splenectomy in selected cases
  5. HEMATOPOIETIC STEM CELL TRANSPLANT — the only cure
The exam point: transfusion is the treatment, but IRON OVERLOAD is the consequence — so chelation always accompanies it. Do NOT give iron supplements. The most common cause of death in thalassemia major is HEART FAILURE from cardiac iron toxicity.

Sources for this card

  • Textbook McCance Ch. 30 — beta-thalassemia

    Transfusion, chelation and HSCT as the only cure are confirmed verbatim by Ch. 30. The named chelating agents are not in the chapter, and the book ties folic acid and splenectomy to intermedia.

Careful: this card's wording claims more than its sources give it — including, on some cards, a chapter reference nobody has checked yet. Treat any citation in the text above as unconfirmed unless it appears in this list.

Open one and check this card against it. If it disagrees, that is worth reporting.

Implications for giving attenuated vaccines to compromised individuals

Topic 23 of 73 textbook

Rule: live attenuated vaccines are contraindicated in significantly immunocompromised individuals. These vaccines contain a weakened but still-living version of the organism — in someone whose immune system can't keep it in check, it can replicate unchecked and cause the actual disease it was meant to prevent.

Live vaccines to know:

  • MMR
  • Varicella
  • Zoster (the live formulation)
  • Yellow fever
  • Oral polio
  • Intranasal influenza (FluMist)
  • BCG
  • Rotavirus
  • Oral typhoid

Who to avoid them in:

  • Patients on chemotherapy
  • High-dose corticosteroids
  • Transplant recipients
  • HIV with a low CD4 count
  • Primary immunodeficiency
  • Pregnancy

Inactivated vaccines, by contrast, are safe in these patients:

  • Intramuscular influenza
  • Pneumococcal
  • Tdap
  • COVID
  • Hepatitis

Webinar question to hold onto: a patient on chemotherapy with a WBC of 1.5 is neutropenic. The priority for that patient is infection prevention — not giving a live vaccine.

What “live attenuated” actually means:

The organism is weakened so it can't cause disease — but it is still alive. That is the entire risk in one word. Alive is exactly what lets it start replicating again in someone whose immune system can't hold it down. Compare inactivated: killed outright, so it can't replicate in anybody, which is why those are the safe ones.

The book's full list of vaccine types (useful for a matching question):

  • Live-attenuated and inactivated — the whole organism, either weakened or killed
  • Subunit / recombinant / polysaccharide / conjugate — just a piece of the microbe (hepatitis B, pneumococcus)
  • Toxoid — part of the toxin rather than the microbe (diphtheria, tetanus)
  • Nucleic acid / mRNA — the newest kind (the COVID vaccines)
Be aware: the rule at the top of this card — that live vaccines are contraindicated if you're immunocompromised — is standard practice and it's on your official topic list, but we couldn't find it stated in anything we have. Ch. 10 defines the vaccine types without saying it, and Ch. 9 never mentions vaccines. Worth confirming, and telling us where you find it.
Where your course touches this. Your week 1 slide 67 asks about a chemotherapy patient with a white count of 1.5 and offers "immunization with live vaccine" as one of the answers — the right answer being infection prevention. So the course clearly treats live vaccination as the wrong move in someone immunocompromised. But notice what that is: a wrong option in a practice question, not the rule written down. Your textbook sorts the vaccine types and never states the contraindication either. Where it IS asked outright is eDapt — you confirmed a module asks about immunocompromised patients avoiding live vaccines. So this is not a maybe: it is a question your course puts to you directly. Nobody here can open eDapt, so if its wording differs from this card, trust eDapt.
RULE: LIVE ATTENUATED VACCINES ARE CONTRAINDICATED in significantly immunocompromised individuals. The weakened organism can replicate unchecked and cause actual disease.
  • Live vaccines to know: MMR, varicella, zoster (live formulation), yellow fever, oral polio, intranasal influenza (FluMist), BCG, rotavirus, oral typhoid
  • Who to avoid them in: patients on chemotherapy, high-dose corticosteroids, transplant recipients, HIV with low CD4 count, primary immunodeficiency, and pregnancy
  • Inactivated vaccines are safe: intramuscular influenza, pneumococcal, Tdap, COVID, hepatitis
  • What “live attenuated” actually means (Ch. 10). The organism is rendered unable to cause disease but is still alive. That is the whole risk: alive is exactly what lets it replicate in someone who cannot control it. Contrast INACTIVATED — killed outright, so it cannot replicate in anyone.
  • The book's full vaccine taxonomy, worth knowing for a matching question: LIVE-ATTENUATED and INACTIVATED (whole organism); SUBUNIT, recombinant, peptide, polysaccharide, capsid and CONJUGATE (a piece of the microbe — e.g. hepatitis B, pneumococcus); TOXOID (part of the toxin — e.g. diphtheria, tetanus); and NUCLEIC ACID / mRNA (the COVID vaccines).
  • The contraindication rule at the top of this card is still unsourced. Ch. 10 defines the vaccine types but never says live vaccines are contraindicated in the immunocompromised, and Ch. 9 does not mention vaccines at all. The rule is standard practice and is on the official topic list — but nothing we hold states it, so confirm it and tell us where you find it.

Webinar question: a patient on chemotherapy with a WBC of 1.5 is neutropenic. The priority is INFECTION PREVENTION — not a live vaccine.

▤ Where this is asked. You confirmed an eDapt module asks this directly — immunocompromised patients avoiding live vaccines. That matters, because everywhere else it is only implied: week 1 slide 67 offers live vaccination as a wrong answer without stating the rule, and Ch. 10 sorts the vaccine types without stating it either. We hold no copy of eDapt, so the wording there is the one to trust over this card.

Sources for this card

  • Textbook McCance Ch. 10 — Vaccines and Protection Against Infection

    Defines live-attenuated as rendered unable to cause disease but still living, against inactivated (killed), and gives the full taxonomy — subunit, recombinant, conjugate, toxoid, nucleic acid/mRNA — with examples. It never states the contraindication in the immunocompromised, which is this concept's title.

  • Slides Week 1 deck, slide 67 — practice question on the neutropenic patient

    Offers immunization with a live vaccine as one option for a chemotherapy patient with a white count of 1.5, and answers infection prevention. Treats live vaccination as the wrong choice without stating the rule.

  • Assignment eDapt module — a question on live vaccines in immunocompromised patients; reported, not held

    The reader reports an eDapt module asks directly about immunocompromised patients avoiding live vaccines — the rule asked outright rather than implied by a wrong answer. WE HOLD NO COPY, so nothing here is checked against the module.

  • ·Topic list Official topic list — an examinable topic

Only part of this card is covered by the sources listed. The rest is not yet backed by anything we hold.

Open one and check this card against it. If it disagrees, that is worth reporting.